ATAI AtaiBeckley Inc.

NASDAQ
$7.26

AtaiBeckley Inc. (ATAI) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.3% since its last earnings release on August 11, 2026.

AtaiBeckley Beat Consensus Estimates
Tuesday, August 11, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 8:00 AM ET
Earnings Whisper
-
vs ($0.11)
Rev est $1.54M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.24

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AtaiBeckley Inc.

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow